Effect of infliximab on quality of life in patients with ankylosing spondylitis according to sf-36 questionnaire data

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Quality of life of patients with implantable cardioverser-defibrillator: the usage of SF-36 questionnaire.

OBJECTIVE To observe the quality of life of patients with implantable cardioverser-defibrillator (ICD). METHODS Descriptive research with quantitative approach by means of an interview and the analysis of the Questionnaire SF-36 in a cardiovascular outpatient service. Fifty patients users of this device participated in this study during their medical follow-up in the period from January to De...

متن کامل

Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire.

INTRODUCTION Cystic fibrosis (CF) is a genetic disorder, which is most common among Caucasians. There are about 100,000 people suffering from this disorder in the world, including 25 000 in Europe. Although the first mention of cystic fibrosis is thought to have occurred in 1595, recognition of the entire clinical spectrum of CF and the resultant development of contemporary knowledge occurred i...

متن کامل

Frequency of cardiac involvement among patients with Ankylosing Spondylitis

Background and aims: Ankylosing spondylitis (AS) is an idiopathic chronic inflammatory disease mainly involves sacroiliac and axial joints; but it may also have extra-articular involvement. Accordingly, this study was designed to determine the frequency of cardiac involvement among patients with ankylosing spondylitis. Methods: This study was performed as a descriptive-analytical cross-se...

متن کامل

Management of ankylosing spondylitis with infliximab

Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease responsible for back pain, stiffness and progressive loss of functional capacity with limited therapeutic options. Regular physical exercises together with the use of nonsteroidal antiinflammatory drugs are the two recognized treatment options in AS. Infliximab is a chimeric anti-tumor necrosis factor-α monoclonal antibody...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Modern Rheumatology Journal

سال: 2013

ISSN: 2310-158X,1996-7012

DOI: 10.14412/1996-7012-2013-13